A Study of Updated mRNA Seasonal Influenza Vaccines
NCT07884175
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the immunogenicity and safety of updated strain-containing compositions of the mRNA-1010 vaccines within the current epidemiological environment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Seasonal Influenza
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- ModernaTX, Inc.
- Last updated on ClinicalTrials.gov
- November 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Arizona Clinical Trials · Tucson, AZ
Kansas · 1
- Johnson County Clin-Trials LLC (JCCT) · Lenexa, KS
Kentucky · 1
- DelRicht Research at Derby City Direct Primary Care · Louisville, KY
Missouri · 1
- DelRicht Research at Amy Roberts MD and Associates · Town and Country, MO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.